Literature DB >> 7537559

Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and tryptophan in plasma and urine by HPLC with fluorimetric detection.

C P Bearcroft1, M J Farthing, D Perrett.   

Abstract

Using native fluorescence detection, 5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic acid (5-HIAA) and tryptophan were resolved from themselves and other naturally occurring compounds using reversed-phase HPLC within 5 min. Deproteinated platelet-poor plasma (PPP) and crude diluted urine were injected directly into the chromatograph. Careful selection of the HPLC column is important and various octadecyl silica (ODS) and base deactivated silic (BDS) columns were evaluated. Pre-treatment of an ODS column with tetrabutylammonium ions gave good selectivity. Between pH 5 and 6 the compounds were well resolved from each other. The limit of quantitative detection of 5-HT and 5-HIAA was 3.5 nmol/L. The overall chromatogram obtained using native fluorescence is cleaner than that obtained with the more commonly employed electrochemical (EC) systems although the chromatography is effectively the same. For analysis of 5-HT in plasma, collection in EDTA was more efficient than lithium heparin. Plasma 5-HT in healthy volunteers was mean 61 (SD = +/- 73) nmol/L, n = 20; urine 5-HIAA gave mean 28.95 (SD = +/- 0.98) mumol/L, (n = 12). Whole blood 5-HT analysis is unreliable in comparison with platelet-poor plasma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537559     DOI: 10.1002/bmc.1130090105

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  10 in total

1.  Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.

Authors:  S M Dursun; A Szemis; H Andrews; P Whitaker; M A Reveley
Journal:  J Psychiatry Neurosci       Date:  2000-09       Impact factor: 6.186

2.  Proabsorptive and prosecretory roles for nitric oxide in cholera toxin induced secretion.

Authors:  J L Turvill; F H Mourad; M J Farthing
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

3.  Cisplatin impairs fluid and electrolyte absorption in rat small intestine: a role for 5-hydroxytryptamine.

Authors:  C P Bearcroft; P Domizio; F H Mourad; E A André; M J Farthing
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  The inhibition of cholera toxin-induced 5-HT release by the 5-HT(3) receptor antagonist, granisetron, in the rat.

Authors:  J L Turvill; P Connor; M J Farthing
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

6.  5-hydroxytryptamine release into human jejunum by cholera toxin.

Authors:  C P Bearcroft; D Perrett; M J Farthing
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

7.  Apparent Correlations Between AMPK Expression and Brain Inflammatory Response and Neurological Function Factors in Rats with Chronic Renal Failure.

Authors:  Li Yang; Ni-Rong Gong; Qin Zhang; Ya-Bin Ma; Hui Zhou
Journal:  J Mol Neurosci       Date:  2019-03-27       Impact factor: 3.444

8.  Type A Trichothecene Diacetoxyscirpenol-Induced Emesis Corresponds to Secretion of Peptide YY and Serotonin in Mink.

Authors:  Qinghua Wu; Kamil Kuca; Eugenie Nepovimova; Wenda Wu
Journal:  Toxins (Basel)       Date:  2020-06-25       Impact factor: 4.546

9.  Serotonin and Tryptophan Serum Concentrations in Shelter Dogs Showing Different Behavioural Responses to a Potentially Stressful Procedure.

Authors:  Giacomo Riggio; Chiara Mariti; Valeria Sergi; Silvana Diverio; Angelo Gazzano
Journal:  Vet Sci       Date:  2020-12-24

10.  A new spectrofluorimetric method for determination of trace amounts 5-hydroxytryptamine in human urine and serum.

Authors:  Qian Peng; Chongqiu Jiang
Journal:  J Fluoresc       Date:  2007-04-18       Impact factor: 2.525

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.